首页 | 本学科首页   官方微博 | 高级检索  
检索        

参葛方防治大鼠非酒精性脂肪肝的实验研究
引用本文:齐艳平,李曼,孙学华,朱晓骏,高月求.参葛方防治大鼠非酒精性脂肪肝的实验研究[J].中国实验方剂学杂志,2012,18(12):156-160.
作者姓名:齐艳平  李曼  孙学华  朱晓骏  高月求
作者单位:上海中医药大学附属曙光医院,上海市中医临床重点实验室,肝肾疾病病证教育部重点实验室,上海201203
基金项目:国家自然科学基金(81072792,81102570);国家中医药管理局中医肝胆病重点学科(2010sh);"十一五"国家科技重大专项(2008ZX10005-006);上海市自然科学基金(10ZR1430900);上海高校创新团队建设项目(第一期);上海市教育委员会重点学科(第5期,J50307);上海市科委优秀学科带头人(10XD1404100);上海中医药大学优秀团队培养计划;浦东新区中医领军型人才项目
摘    要:目的:研究参葛方对CCl4复合高脂低蛋白饮食诱导的非酒精性脂肪肝模型大鼠的防治作用.方法:运用四氯化碳( carbon tetrachloride,CCl4)皮下注射4周(2次/周)复合高脂低蛋白饮食2周诱导非酒精性脂肪肝(non-alcoholic fatty liver,NAFL)动物模型,造模大鼠在造模第1天开始随机分为正常组、模型组、参葛方组及阳性药物对照组,自造模之日起参葛方高、中、低剂量组给药分别为0,10,5 g·kg-1,易善复组剂量为0.076 g·kg-1并ig给药或蒸馏水.处理后,观察药物对大鼠血清肝功能、肝脏组织病理变化、肝组织甘油三酯( triglyceride,TG)、游离脂肪酸(free fatty acid,FFA)含量,及丙二醛( malondialdehyde,MDA)和超氧化物歧化酶(superoxide dismutase,SOD)活性变化的影响.结果:与模型组相比,参葛方治疗组大鼠血清丙氨酸转氨酶( ALT,68.00±17.84,52.50±18.03)U·L-1,天冬氨酸转氨酶( AST,382.66±109.78,291.30±74.33)U·L-1显著降低(P<0.01),肝组织脂肪变性明显改善,肝组织SOD活性有升高趋势,肝组织MDA( 370.25±61.28,249.82±15.98)nmo1·g-1含量显著下降(P<0.01).结论:参葛方可显著降低CCl4结合高脂低蛋白饮食诱导的大鼠脂肪肝模型中TG 和FFA含量,减轻炎症损伤和肝脂肪变性,抗脂质过氧化作用,对NAFL动物模型有理想疗效.

关 键 词:参葛方  非酒精性脂肪肝  动物模型  游离脂肪酸  超氧化物歧化酶  丙二醛
收稿时间:2011/8/23 0:00:00

Experimental Study on Prevention and Treatment by Shenge Formula in NAFL Model of Rats
QI Yan-ping,LI Man,SUN Xue-hu,ZHU Xiao-jun and GAO Yue-qiu.Experimental Study on Prevention and Treatment by Shenge Formula in NAFL Model of Rats[J].China Journal of Experimental Traditional Medical Formulae,2012,18(12):156-160.
Authors:QI Yan-ping  LI Man  SUN Xue-hu  ZHU Xiao-jun and GAO Yue-qiu
Institution:Shuguang Hospital Affliated to Shangkai University of Traditional Chinese Medicine (TCM), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Key Laboratory of Liver and Kidney Diseases (Shanghai University of TCM) Ministry of Education, Shanghai 200021, China;Shuguang Hospital Affliated to Shangkai University of Traditional Chinese Medicine (TCM), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Key Laboratory of Liver and Kidney Diseases (Shanghai University of TCM) Ministry of Education, Shanghai 200021, China;Shuguang Hospital Affliated to Shangkai University of Traditional Chinese Medicine (TCM), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Key Laboratory of Liver and Kidney Diseases (Shanghai University of TCM) Ministry of Education, Shanghai 200021, China;Shuguang Hospital Affliated to Shangkai University of Traditional Chinese Medicine (TCM), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Key Laboratory of Liver and Kidney Diseases (Shanghai University of TCM) Ministry of Education, Shanghai 200021, China;Shuguang Hospital Affliated to Shangkai University of Traditional Chinese Medicine (TCM), Shanghai Key Laboratory of Traditional Chinese Clinical Medicine,Key Laboratory of Liver and Kidney Diseases (Shanghai University of TCM) Ministry of Education, Shanghai 200021, China
Abstract:Objective: To study the prevention and treatment action of Shenge formula on CCl4 combined with high-fat and low-protein diet induced non-alcoholic fatty liver (NAFL) model. Method: The rat NAFL model was established by subcutaneous injection of carbon tetrachloride (CCl4) for 4 weeks twice per week combined with high-fat and low-protein diet for 2 weeks. All rats were randomly grouped into normal group, model group, Shenge formula group and positive drug group. Distilled water and corresponding drugs were administered by intragastric administration method every day. After rats were sacrificed, the serum aminotransferase value, liver pathological changes and triglyceride(TG),free fatty acid(FFA) level, malondialdehyde(MDA)and superoxide dismutase (SOD) were examined. Result: Compared with model group, serum ALT and AST value were significantly decreased in Shenge formula group, and the MDA level in liver was significantly decreased in Shenge formula group(P<0.01). In addition, hepatic steatosis was significantly improved in Shenge formula. Conclusion: Shenge formula has protective effects on steatohepatitis, and it can significantly decrease the levels of TG and FFA, and improve inflammatory injury and hepatic steatosis, and anti-lipid peroxidation injury in the NAFL model.
Keywords:Shenge formula  non-alcoholic fatty liver  animal model  free fatty acid  superoxide dismutase  malondialdehyde
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号